贝瑞基因(000710) - 2022 Q3 - 季度财报

Financial Summary Key Performance Indicators In Q3 2022, the company's operating revenue slightly decreased by 1.54%, but net profit attributable to parent company shareholders significantly increased by 175.95% to 2.42 million Yuan; year-to-date, cumulative operating revenue declined by 5.32%, resulting in a net loss of 16.19 million Yuan, a reversal from profit, and total assets decreased by 5.20% from the end of the previous year Key Financial Data and Indicators | Indicator | Current Period (Q3 2022) | Year-on-Year Change | Year-to-Date (YTD Q3 2022) | Year-on-Year Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue (Yuan) | 373,042,626.05 | -1.54% | 1,053,341,449.12 | -5.32% | | Net Profit Attributable to Shareholders of Listed Company (Yuan) | 2,420,719.25 | 175.95% | -16,194,159.31 | -157.74% | | Net Profit Attributable to Shareholders of Listed Company (Excluding Non-recurring Gains and Losses) (Yuan) | -1,905,288.43 | 41.23% | -22,154,823.00 | -181.51% | | Basic Earnings Per Share (Yuan/Share) | 0.0068 | 176.08% | -0.0458 | -157.90% | | Net Cash Flow from Operating Activities (Yuan) | — | — | -26,985,970.24 | 71.43% | Balance Sheet Indicators | Balance Sheet Indicator | End of Current Period | Change from End of Previous Year | | :--- | :--- | :--- | | Total Assets (Yuan) | 3,336,599,602.86 | -5.20% | | Total Equity Attributable to Shareholders of Listed Company (Yuan) | 2,489,562,342.04 | -0.03% | Non-recurring Gains and Losses Year-to-date, the company's total non-recurring gains and losses amounted to 5.96 million Yuan, primarily from government grants included in current profit or loss, which positively impacted current period profit Non-recurring Gains and Losses Items and Amounts | Item | Amount Year-to-Date (Yuan) | | :--- | :--- | | Gains/Losses on Disposal of Non-current Assets | 800.02 | | Government Grants Included in Current Profit/Loss | 6,589,721.99 | | Net Non-operating Income and Expenses | 512,018.65 | | Other Gains and Losses Meeting the Definition of Non-recurring Gains and Losses | -3,095,550.50 | | Total | 5,960,663.69 | Analysis of Financial Position Changes During the reporting period, the company's financial position changed significantly: cash decreased due to procurement and repayments, development expenditures increased from R&D; short-term borrowings declined; operating profit turned negative due to lower gross margin; operating cash flow improved despite remaining negative; investing cash outflow decreased; and financing cash flow turned negative due to loan repayments Balance Sheet Item Changes Analysis As of the end of the reporting period, the company's cash and cash equivalents significantly decreased by 46.25% due to procurement payments and loan repayments, while prepayments and development expenditures increased by 115.09% and 56.26% respectively, reflecting increased purchasing and R&D investment; short-term borrowings decreased by 41.79%, and deferred income surged by 238.59% from government grants Balance Sheet Item Changes | Balance Sheet Item | Change Percentage | Reason for Change | | :--- | :--- | :--- | | Cash and Cash Equivalents | -46.25% | Primarily due to payments for raw materials, fixed asset purchases, and loan repayments | | Prepayments | 115.09% | Primarily due to payments for purchases | | Development Expenditures | 56.26% | Primarily due to R&D investment | | Short-term Borrowings | -41.79% | Primarily due to a decrease in loan size | | Deferred Income | 238.59% | Primarily due to receipt of government grants | | Other Comprehensive Income | 2757.54% | Primarily due to the impact of exchange rate changes on the translation of foreign currency financial statements | Income Statement Item Changes Analysis Year-to-date, the company's operating profit turned into a loss of 7.68 million Yuan, a 117.16% year-on-year decrease, primarily due to a decline in gross profit margin during the reporting period - Year-to-date, operating profit decreased by 117.16% year-on-year, turning into a loss of 7.68 million Yuan, primarily due to a decline in gross profit margin during the current reporting period[9] Cash Flow Statement Item Changes Analysis Year-to-date, net cash flow from operating activities was -26.99 million Yuan, a 71.43% improvement year-on-year due to reduced tax payments and tax refunds; net cash outflow from investing activities significantly narrowed by 83.00% as no capital increase to associates occurred this period; and net cash flow from financing activities turned negative, decreasing by 224.71%, primarily due to loan repayments and prior period employee stock plan receipts - Net cash flow from operating activities improved by 71.43% year-on-year, primarily due to a decrease in taxes and fees paid and the receipt of tax refunds[9] - Net cash flow from investing activities improved by 83.00% year-on-year, primarily because the previous year included a capital increase to an associate company, which did not occur in the current period[9] - Net cash flow from financing activities decreased by 224.71% year-on-year, primarily due to the company's repayment of bank loans in the current reporting period and the receipt of funds from the employee stock ownership plan in the previous year[9] Shareholder Information Major Shareholder Holdings As of the end of the reporting period, the company had 42,748 common shareholders, with Chengdu Tianxing Instrument (Group) Co., Ltd., Gao Yang, and Hongling Siqi (Zhuhai) M&A Equity Investment Enterprise as the top three shareholders, and Hou Ying identified as a concerted party of Gao Yang - The total number of common shareholders at the end of the reporting period was 42,748[10] Top Shareholders' Holdings | Shareholder Name | Shareholding Percentage | Number of Shares Held | | :--- | :--- | :--- | | Chengdu Tianxing Instrument (Group) Co., Ltd. | 12.41% | 44,002,000 | | Gao Yang | 11.37% | 40,310,572 | | Hongling Siqi (Zhuhai) M&A Equity Investment Enterprise | 8.46% | 30,000,000 | | Hou Ying | 6.59% | 23,355,661 | - Shareholder Ms. Hou Ying is a concerted party of Mr. Gao Yang[11] Financial Statements Consolidated Balance Sheet As of September 30, 2022, the company's total assets were 3.337 billion Yuan, a 5.20% decrease from the beginning of the year; total liabilities were 820 million Yuan, down 17.72%; and total equity attributable to the parent company was 2.490 billion Yuan, largely unchanged from the year's start Consolidated Balance Sheet Data | Item | September 30, 2022 (Yuan) | January 1, 2022 (Yuan) | | :--- | :--- | :--- | | Cash and Cash Equivalents | 224,626,713.14 | 417,889,295.07 | | Accounts Receivable | 1,182,245,783.35 | 1,103,422,716.44 | | Inventories | 295,888,379.22 | 233,881,659.24 | | Fixed Assets | 790,195,968.62 | 841,437,298.43 | | Total Assets | 3,336,599,602.86 | 3,519,721,822.69 | | Short-term Borrowings | 110,905,084.70 | 190,537,791.45 | | Accounts Payable | 295,323,471.41 | 339,928,924.23 | | Total Liabilities | 819,516,004.62 | 996,019,770.26 | | Total Equity | 2,517,083,598.24 | 2,523,702,052.43 | Consolidated Income Statement (Year-to-Date) In the first three quarters of 2022, the company's operating revenue was 1.053 billion Yuan, a 5.32% year-on-year decrease; despite relatively stable operating cost control, the impact of various expenses and investment losses led to an operating loss of 7.68 million Yuan, with net profit attributable to parent company shareholders being a loss of 16.19 million Yuan, compared to a profit of 28.04 million Yuan in the prior year Consolidated Income Statement Data | Item | Current Period Amount (YTD Q3 2022) | Prior Period Amount (YTD Q3 2021) | | :--- | :--- | :--- | | Total Operating Revenue | 1,053,341,449.12 | 1,112,497,418.39 | | Operating Costs | 573,790,822.25 | 584,915,983.08 | | Selling Expenses | 214,858,630.64 | 213,640,281.13 | | Administrative Expenses | 125,412,655.09 | 111,611,523.15 | | Research and Development Expenses | 77,127,746.32 | 91,266,348.09 | | Investment Income | -44,602,394.05 | -39,152,709.77 | | Operating Profit | -7,683,184.13 | 44,785,399.00 | | Total Profit | -5,194,754.02 | 45,801,551.92 | | Net Profit Attributable to Parent Company Shareholders | -16,194,159.31 | 28,044,947.46 | Consolidated Cash Flow Statement (Year-to-Date) In the first three quarters of 2022, net cash flow from operating activities was -26.99 million Yuan, from investing activities was -45.64 million Yuan, and from financing activities was -133.32 million Yuan; cash and cash equivalents decreased by 193.26 million Yuan, with an ending balance of 223.36 million Yuan Consolidated Cash Flow Statement Data | Item | Current Period Amount (YTD Q3 2022) | Prior Period Amount (YTD Q3 2021) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -26,985,970.24 | -94,466,440.00 | | Net Cash Flow from Investing Activities | -45,641,577.81 | -268,549,931.64 | | Net Cash Flow from Financing Activities | -133,318,381.68 | 106,904,431.52 | | Net Increase in Cash and Cash Equivalents | -193,262,581.93 | -256,998,274.46 | | Cash and Cash Equivalents at End of Period | 223,362,321.41 | 372,310,024.48 |